Not 100% sure but according to Coppo report, MS (Morgan Stanley I presume) raised target price 35% to $14.20.
- Forums
- ASX - By Stock
- 360
- Ann: Presentation - Goldman Sachs Emerging Technology Conference
Ann: Presentation - Goldman Sachs Emerging Technology Conference, page-11
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 360 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$23.92 |
Change
-0.030(0.13%) |
Mkt cap ! $4.396B |
Open | High | Low | Value | Volume |
$24.22 | $24.64 | $23.70 | $13.31M | 554.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 1353 | $23.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$23.94 | 234 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 520 | 23.940 |
5 | 565 | 23.930 |
1 | 50 | 23.920 |
2 | 230 | 23.910 |
5 | 1071 | 23.900 |
Price($) | Vol. | No. |
---|---|---|
23.950 | 848 | 11 |
23.960 | 170 | 2 |
23.970 | 32 | 1 |
23.980 | 165 | 2 |
23.990 | 245 | 3 |
Last trade - 13.47pm 12/11/2024 (20 minute delay) ? |
Featured News
360 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online